A Study Evaluating the Safety and Efficacy of RDX013 for the Treatment of Hyperkalemia
NCT04780841
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
109
Enrollment
INDUSTRY
Sponsor class
Conditions
Hyperkalemia
Interventions
DRUG:
RDX013
DRUG:
Placebo
Sponsor
Ardelyx